Ix Joachim H, Shlipak Michael G, Katz Ronit, Budoff Matthew J, Shavelle David M, Probstfield Jeffrey L, Takasu Junichiro, Detrano Robert, O'Brien Kevin D
Department of Medicine, University of California, San Francisco, CA 94143-0532, USA.
Am J Kidney Dis. 2007 Sep;50(3):412-20. doi: 10.1053/j.ajkd.2007.05.020.
Aortic valve calcification (AVC) and mitral annular calcification (MAC) are highly prevalent and predictive of mortality in end-stage renal disease populations. Whether less severe kidney dysfunction is associated with AVC and MAC is uncertain.
Cross-sectional study.
SETTING & PARTICIPANTS: Ethnically diverse middle-aged adults without clinically apparent cardiovascular disease who participated in the Multi-Ethnic Study of Atherosclerosis.
Estimated glomerular filtration rate (eGFR), cystatin C, and microalbuminuria.
OUTCOMES & MEASUREMENTS: AVC and MAC were determined by means of computed tomography. Multivariable logistic regression evaluated the association of kidney function with AVC and MAC.
Of 6,785 participants, 10% had an eGFR less than 60 mL/min/1.73 m(2) (<1.0 mL/s/1.73 m(2)), mean cystatin C level was 0.9 +/- 0.2 mg/L, 7% had microalbuminuria (albumin >or= 30 mg/g), 15% had diabetes, 13% had AVC, and 9% had MAC. In adjusted analyses for AVC, eGFR less than 60 mL/min/1.73 m(2) (adjusted odds ratio, 1.23; 95% confidence interval, 0.99 to 1.14) and greater cystatin C concentrations (per SD increase; adjusted odds ratio, 1.06; 95% confidence interval, 0.99 to 1.14) had modest associations. Microalbuminuria was not associated independently with AVC (adjusted odds ratio, 1.11; 95% confidence interval, 0.89 to 1.40). For the MAC end point, associations of eGFR less than 60 mL/min/1.73 m(2) and greater cystatin C level differed by diabetes status (P for interaction = 0.1 and 0.02, respectively). In persons with diabetes, eGFR less than 60 mL/min/1.73 m(2) (adjusted odds ratio, 2.03; 95% confidence interval, 1.26 to 3.25) and greater cystatin C level (adjusted odds ratio, 1.38; 95% confidence interval, 1.14 to 1.68) were associated strongly, whereas no association was observed in subjects without diabetes (eGFR < 60 mL/min/1.73 m(2): adjusted odds ratio, 1.13; 95% confidence interval, 0.86 to 1.49; cystatin C: adjusted odds ratio, 1.03; 95% confidence interval, 0.93 to 1.13). The association of microalbuminuria with MAC (adjusted odds ratio, 1.37; 95% confidence interval, 1.06 to 1.76) did not differ by diabetes status (P for interaction = 0.2).
There were few participants with severe kidney disease.
Impaired kidney function had only a modest association with AVC, whereas its association with MAC was observed only in persons with diabetes. Future studies should evaluate whether associations of kidney impairment with dystrophic calcification differ by diabetes status in other clinical settings and vascular beds.
主动脉瓣钙化(AVC)和二尖瓣环钙化(MAC)在终末期肾病患者中非常普遍,且可预测死亡率。肾功能轻度受损是否与AVC和MAC相关尚不确定。
横断面研究。
参加动脉粥样硬化多民族研究的无明显临床心血管疾病的不同种族中年成年人。
估计肾小球滤过率(eGFR)、胱抑素C和微量白蛋白尿。
通过计算机断层扫描确定AVC和MAC。多变量逻辑回归评估肾功能与AVC和MAC的关联。
在6785名参与者中,10%的人eGFR低于60 mL/min/1.73 m²(<1.0 mL/s/1.⁷³ m²),平均胱抑素C水平为0.9±0.2 mg/L,7%的人有微量白蛋白尿(白蛋白≥30 mg/g),15%的人有糖尿病,13%的人有AVC,9%的人有MAC。在对AVC的校正分析中,eGFR低于60 mL/min/1.73 m²(校正比值比,1.23;95%置信区间,0.99至1.14)和较高的胱抑素C浓度(每标准差增加;校正比值比,1.06;95%置信区间,0.99至1.14)有适度关联。微量白蛋白尿与AVC无独立关联(校正比值比,1.11;95%置信区间,0.89至1.40)。对于MAC终点,eGFR低于60 mL/min/1.73 m²和较高的胱抑素C水平的关联因糖尿病状态而异(交互作用P值分别为0.1和0.02)。在糖尿病患者中,eGFR低于60 mL/min/1.73 m²(校正比值比,2.03;95%置信区间,1.26至3.25)和较高的胱抑素C水平(校正比值比,1.38;95%置信区间,1.14至1.68)有强烈关联,而在无糖尿病的受试者中未观察到关联(eGFR<60 mL/min/1.73 m²:校正比值比,1.13;95%置信区间,0.86至1.49;胱抑素C:校正比值比,1.03;95%置信区间,0.93至1.13)。微量白蛋白尿与MAC的关联(校正比值比,1.37;95%置信区间,1.06至1.76)在糖尿病状态下无差异(交互作用P值=0.2)。
严重肾病患者较少。
肾功能受损与AVC仅有适度关联,而其与MAC的关联仅在糖尿病患者中观察到。未来研究应评估在其他临床环境和血管床中,肾功能损害与营养不良性钙化的关联是否因糖尿病状态而异。